Generate a tailored SOP for Dr. Trang Hoang. Improve your application with a focused, well-structured draft.
Early in her career, Trang Hoang became interested in leukemia and stem cells. She has long directed interdisciplinary and multidisciplinary Master’s and Doctoral programs in molecular biology at the Université de Montréal (UdeM). This renowned researcher discovered abnormal cells that cause certain acute lymphoblastic leukemias, common cancers in children. In 2003, she helped found the Institute for Research in Immunology and Cancer (IRIC) in Montreal, quickly taking the lead of the research laboratory on hematopoiesis and leukemia. She started teaching at the Department of Pharmacology and Physiology of UdeM in the same year. Her current research focuses on acute leukemia and the mechanisms that induce leukemia development, with the objective of making a difference for patients. She has made significant contributions to understanding hematopoietic stem cells and the pathways involved in leukemia development, utilizing a multidisciplinary approach that combines molecular genetics, functional genomics, and proteomics analysis. She has published extensively in her field and is recognized for her impactful scientific contributions.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.